SK285271B6 - Method for producing 4-[(2',5'-diamino-6'-halopyrimidine-4'- yl)amino]-cyclopent-2-enylmethanols - Google Patents
Method for producing 4-[(2',5'-diamino-6'-halopyrimidine-4'- yl)amino]-cyclopent-2-enylmethanols Download PDFInfo
- Publication number
- SK285271B6 SK285271B6 SK569-2001A SK5692001A SK285271B6 SK 285271 B6 SK285271 B6 SK 285271B6 SK 5692001 A SK5692001 A SK 5692001A SK 285271 B6 SK285271 B6 SK 285271B6
- Authority
- SK
- Slovakia
- Prior art keywords
- diamino
- amino
- cyclopent
- enylmethanols
- formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/50—Three nitrogen atoms
Abstract
Description
Oblasť technikyTechnical field
Predložený vynález sa týka nového spôsobu výroby 4-[(2',5'-diamino-6'-halogénpyrimidin-4'-yl)amino]cyklopent-2-enylmetanolov. 4-[(2',5'-Diamino-6'-halogénpyrimidin-4'-yl)amino]cyklopent-2-enylmetanoly sú dôležité medziprodukty na výrobu antivirálnych derivátov nukleotidov (WO 91/01310).The present invention relates to a novel process for the preparation of 4 - [(2 ', 5'-diamino-6'-halopyrimidin-4'-yl) amino] cyclopent-2-enylmethanols. 4 - [(2 ', 5'-Diamino-6'-halopyrimidin-4'-yl) amino] cyclopent-2-enylmethanols are important intermediates for the production of antiviral nucleotide derivatives (WO 91/01310).
Doterajší stav technikyBACKGROUND OF THE INVENTION
Známa je 3-stupňová syntéza 4-[2',5'-diamino-6'-halogénpyrimidin-4’-yl)amino]cyklopent-2-enylmetanolu zo 4-acetamidocyklopent-2-enylmetanolu reakciou s 2-amino-4,6-dichlórpyrimidinu v butanole pomocou diizopropyletylamínu ako zásady. Pritom sa najprv vytvorí [(2’-amino-6'-chlórpyrimidin-4'-yl)amino]cyklopent-2-enylmetanol, ktorý sa potom diazotáciou v nasledujúcom stupni premení na zodpovedajúci atnín, ktorý sa potom hydrolyzuje na konečný produkt (J. Chem. Soc. Perkin. Trans., 1, 1992). Nedostatkom tohto spôsobu je nadmerná nákladovosť a menšie výťažky požadovaného konečného produktu.The 3-step synthesis of 4- [2 ', 5'-diamino-6'-halopyrimidin-4'-yl) amino] cyclopent-2-enylmethanol from 4-acetamidocyclopent-2-enylmethanol by reaction with 2-amino-4 is known. 6-dichloropyrimidine in butanol using diisopropylethylamine as the base. In this case, [(2'-amino-6'-chloropyrimidin-4'-yl) amino] cyclopent-2-enylmethanol is formed first, which is then diazotized to the corresponding atine in the next step, which is then hydrolyzed to the final product (J). Chem. Soc. Perkin Trans., 1, 1992). The disadvantage of this method is the excessive cost and lower yields of the desired end product.
Úlohou predloženého vynálezu je poskytnúť jednostupňový a tým lacnejší spôsob výroby 4-[(2',5'-diamino-6'-halogénpyrimidin-4’-yl)amino]cyklopent-2-enylmetanolov, pri ktorej sa požadované produkty získajú v dobrom výťažku.It is an object of the present invention to provide a one-step and thus cheaper process for the preparation of 4 - [(2 ', 5'-diamino-6'-halopyrimidin-4'-yl) amino] cyclopent-2-enylmethanols in which the desired products are obtained in good yield .
Táto úloha sa rieši spôsobom podľa nároku 1.This object is solved by the method of claim 1.
Podstata vynálezuSUMMARY OF THE INVENTION
Pri spôsobe výroby 4-[(2',5'-diamino-6'-halogénpyrimidin-4'-yl)amino]cyklopent-2-enylmctanolov všeobecného vzorca (I)In the process for preparing 4 - [(2 ', 5'-diamino-6'-halopyrimidin-4'-yl) amino] cyclopent-2-enylmethanols of formula (I)
kde X znamená atóm halogénu ako F, Cl, Br alebo 1, prekvapením bolo zistenie nasledujúcej skutočnosti. Ak sa namiesto 2-amino-4,6-dichlórpyrimidínu ako východiskového materiálu použije 2,5-diamino-4,6-dihalogénpyrimidín všeobecného vzorca (II)where X represents a halogen atom such as F, Cl, Br or 1, the following was surprising. When 2,5-diamino-4,6-dihalopyrimidine of formula (II) is used as the starting material in place of 2-amino-4,6-dichloropyrimidine
XX
a ten sa v prítomnosti zásady v polárnom protickom rozpúšťadle nechá reagovať so 4-aminocyklopent-2-enylmetanolom vzorca (111)and this is reacted with 4-aminocyclopent-2-enylmethanol of formula (111) in the presence of a base in a polar protic solvent.
alebo s jeho soľou, získa sa požadovaný konečný produkt všeobecného vzorca (I) niekoľkonásobne lacnejšie a v dobrom výťažku.or a salt thereof, yielding the desired end product of formula (I) several times cheaper and in good yield.
2,5-Diamino-4,6-dihalogénpyrimidíny, ako je 2,5-diamino-4,6-dichlórpyrimidín sa môžu vyrobiť podľa EP-A-0 684 326.2,5-Diamino-4,6-dihalopyrimidines such as 2,5-diamino-4,6-dichloropyrimidine can be prepared according to EP-A-0 684 326.
Ako 4-aminocyklopent-2-enylmetanoly sa môžu použiť tak racemické, ako aj opticky aktívne zlúčeniny, ako (1R,4S)-, (1S,4R)-, (1R,4R)-, alebo (lS,4S)-4-amino-cyklopent-2-enylmetanoly. Vhodné soli sú adičné soli kyselín, najmä hydro-halogenidové soli, napríklad hydrochloridy alebo hydrobromidy. 4-Aminocyklopent-2-enylmetanoly, najmä (1R,4S)-, alebo (lS,4R)-enantioméry sa môžu vyrobiť podľa WO 97/45529.Both racemic and optically active compounds such as (1R, 4S) -, (1S, 4R) -, (1R, 4R) -, or (1S, 4S) -4 can be used as 4-aminocyclopent-2-enylmethanols. amino-cyclopent-2-enylmethanols. Suitable salts are acid addition salts, especially hydrohalide salts, for example hydrochlorides or hydrobromides. 4-Aminocyclopent-2-enylmethanols, especially the (1R, 4S) - or (1S, 4R) -enantiomers can be prepared according to WO 97/45529.
Účelne sa reakcia uskutočňuje v prítomnosti uhličitanu alkalického kovu alebo uhličitanu kovu alkalickej zeminy, hydrogenuhličitanu alkalického kovu alebo hydrogenuhličitanu kovu alkalickej zeminy, alebo v prítomnosti dusíkatých zásad, ako napríklad terc, amínov, ako zásady. Ako uhličitan alkalického kovu alebo hydrogenuhličitan alkalického kovu sa môže použiť uhličitan sodný, uhličitan draselný alebo hydrogenuhličitan sodný, alebo hydrogenuhličitan draselný. Ako uhličitan kovu alkalickej zeminy, prípadne hydrogenuhličitan kovu alkalickej zeminy sa môže použiť uhličitan vápenatý alebo uhličitan horečnatý, alebo hydrogenuhličitan vápenatý. Ako terc, amťny sú vhodné napríklad trietylamín a diizopropyletylamín. Výhodne sa reakcia uskutočňuje v prítomnosti hydrogenuhličitanu alkalického kovu, ako je hydrogenuhličitan sodný alebo v prítomnosti terc, amínu, ako je diizopropyletylamín.Conveniently, the reaction is carried out in the presence of an alkali metal or alkaline earth metal carbonate, an alkali metal bicarbonate or an alkaline earth metal bicarbonate, or in the presence of nitrogenous bases such as tertiary amines such as bases. As the alkali metal carbonate or alkali metal bicarbonate, sodium carbonate, potassium carbonate or sodium bicarbonate, or potassium bicarbonate may be used. As the alkaline earth metal carbonate or alkaline earth metal bicarbonate, calcium carbonate or magnesium carbonate or calcium bicarbonate can be used. Suitable tertiary amines are, for example, triethylamine and diisopropylethylamine. Preferably, the reaction is carried out in the presence of an alkali metal bicarbonate, such as sodium bicarbonate, or in the presence of a tertiary amine, such as diisopropylethylamine.
Zásada sa účelne použije v prebytku, vzťažené na 2,5-diamino-4,6-dihalogénpyrimidín, výhodne sa použijú 1 až 4 móly zásady na mól 2,5-diamino-4,6-di-halogénpyrimidínu.The base is conveniently used in excess based on 2,5-diamino-4,6-dihalopyrimidine, preferably 1 to 4 moles of base per mole of 2,5-diamino-4,6-dihalopyrimidine are used.
Ako poláme protické rozpúšťadlo sú vhodné najmä Cj^alkoholy, ako metanol, etanol, propanol a jeho izoméry a butanol a jeho izoméry.Particularly suitable as the polar protic solvent are C 1-4 alcohols such as methanol, ethanol, propanol and its isomers and butanol and its isomers.
Reakcia sa účelne uskutočňuje pri teplote od 20 °C po teplotu spätného toku zodpovedajúceho rozpúšťadla, výhodne od 50 °C po teplotu spätného toku. Účelne sa 4-aminocyklopent-2-enylmetanol a 2,5-diamino-4,6-dihalogénpyrimidín použijú v ekvimolámom množstve.The reaction is conveniently carried out at a temperature of from 20 ° C to the reflux temperature of the corresponding solvent, preferably from 50 ° C to reflux temperature. Suitably, 4-aminocyclopent-2-enylmethanol and 2,5-diamino-4,6-dihalopyrimidine are used in equimolar amounts.
Po zvyčajnej reakčnej dobe 2 až 20 hodín sa môžu konečné produkty vzorca (I), výhodne (lS,4R)-4-[(2',5'-diamino-6'-halogénpyrimidin-4'-yl)amino]cyklopent-2-enylmetanol, získať zvyčajnými metódami spracovania.After the usual reaction time of 2 to 20 hours, the end products of formula (I), preferably (1S, 4R) -4 - [(2 ', 5'-diamino-6'-halopyrimidin-4'-yl) amino] cyclopent- 2-enylmethanol, obtained by the usual processing methods.
Príklady uskutočnenia vynálezuDETAILED DESCRIPTION OF THE INVENTION
Príklad 1Example 1
Výroba 4-[(2’,5'-diamino-6'-chlórpyrimidin-4'-yl)aminojcyklopent-2-enylmetanolu v prítomnosti hydrogenuhličitanu sodného (1 S,4R)-4-Aminocyklopent-2-enylmetanolhydrochlorid (0,14 molov, 23,25 g), etanol (3 móly, 138,12 g, 176 ml),Preparation of 4 - [(2 ', 5'-diamino-6'-chloropyrimidin-4'-yl) amino] cyclopent-2-enylmethanol in the presence of sodium bicarbonate (1S, 4R) -4-Aminocyclopent-2-enylmethanol hydrochloride (0.14 mole, 23.25 g), ethanol (3 moles, 138.12 g, 176 mL),
2,5-diamino-4,6-dichlórpyrimidm (0,14 molov, 25 g) a hydrogenuhličitan sodný (0,34 molov, 28,68 g) sa vnieslo do suchého reaktora. Táto zmes sa zohrievala až po teplotu spätného toku (cca 80 °C) 16 hodín. Reakčné pomery (rýchlosť) sa testovali pomocou TLC s 13/1 metylénchloridont: metanol ako vyvíjači prostriedok. Reakčná zmes sa ochladila na teplotu miestnosti a miešala sa 45 minút. Soli sa odstránili filtráciou a filtračný koláč sa premyl 2-krát etanolom (0,86 molov, 39,5 g, 50 ml).2,5-diamino-4,6-dichloropyrimide (0.14 mol, 25 g) and sodium bicarbonate (0.34 mol, 28.68 g) were charged to a dry reactor. This mixture was heated to reflux (ca. 80 ° C) for 16 hours. Reaction ratios (rates) were tested by TLC with 13/1 methylene chloride: methanol as a developing agent. The reaction mixture was cooled to room temperature and stirred for 45 minutes. The salts were removed by filtration and the filter cake was washed 2 times with ethanol (0.86 mol, 39.5 g, 50 mL).
Potom, čo sa vákuovou destiláciou odstránili 2/3 organickej fázy, sa po kvapkách pridával hexán (150 ml). Suspenzia sa ochladila pod 10 °C. Po filtrácii sa sušila vákuovo pri 50 °C.After 2/3 of the organic phase was removed by vacuum distillation, hexane (150 mL) was added dropwise. The suspension was cooled below 10 ° C. After filtration, it was dried under vacuum at 50 ° C.
Získalo sa 21,5 g (0,08 molov) konečného produktu, čo zodpovedá 60% výťažku.21.5 g (0.08 mol) of the final product was obtained, corresponding to a 60% yield.
Príklad 2Example 2
Výroba 4-[(2',5'-diamino-6'-chlórpyrimidin-4'-yl)amino]cyklopent-2-enylmetanolu v prítomnosti diizopropyletylamínu (1 S,4R)-4-Aminocyklopent-2-enylmetanolhydrochlorid (0,14 molov, 23,18 g), butanol (1,26 mólov, 93,39 g, 115,3 ml),Preparation of 4 - [(2 ', 5'-diamino-6'-chloropyrimidin-4'-yl) amino] cyclopent-2-enylmethanol in the presence of diisopropylethylamine (1S, 4R) -4-Aminocyclopent-2-enylmethanol hydrochloride 14 mol, 23.18 g) butanol (1.26 mol, 93.39 g, 115.3 mL),
2,5-diamino-4,6-dichlórpyrimidín (0,14 mólov, 25,67 g) a diizopropyletylamín (0,29 mólov, 37,09 g, 49,99 ml) sa vnieslo do suchého reaktora. Táto zmes sa zohrievala cez noc až po teplotu spätného toku (cca 115 °C). Reakčné pomery (rýchlosť) sa testovali pomocou TLC s 13/1 metylénchloridom: metanol ako vyvíjači prostriedok. Reakčná zmes sa ochladila na teplotu miestnosti. Potom sa pridala voda s následným dvojnásobným extrahovaním s etylacetátom.2,5-diamino-4,6-dichloropyrimidine (0.14 mol, 25.67 g) and diisopropylethylamine (0.29 mol, 37.09 g, 49.99 ml) were charged to a dry reactor. The mixture was heated overnight to reflux (ca. 115 ° C). Reaction rates (rate) were tested by TLC with 13/1 methylene chloride: methanol as a developing agent. The reaction mixture was cooled to room temperature. Water was then added followed by extraction twice with ethyl acetate.
Organická fáza sa 2-krát premyla vodou a potom sa organická fáza filtrovala cez Celíte. Potom, čo sa vákuovou destiláciou odstránili 2/3 organickej fázy, sa po kvapkách pridával hexán. Suspenzia sa ochladila pod 10 °C. Po filtrácii sa vákuovo sušila pri 50 °C.The organic phase was washed twice with water and then the organic phase was filtered through Celite. After 2/3 of the organic phase was removed by vacuum distillation, hexane was added dropwise. The suspension was cooled below 10 ° C. After filtration, it was vacuum dried at 50 ° C.
Získalo sa 21,47 g (0,08 mólov) konečného produktu, čo zodpovedá 60 % výťažku.21.47 g (0.08 mol) of the final product was obtained, corresponding to a 60% yield.
Claims (3)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP98120529 | 1998-10-30 | ||
US14610599P | 1999-07-29 | 1999-07-29 | |
PCT/EP1999/008270 WO2000026193A1 (en) | 1998-10-30 | 1999-10-29 | Method for producing 4- [(2',5'- diamino-6'- halopyrimidine- 4'-yl)amino]- cyclopent- 2-enylmethanols |
Publications (2)
Publication Number | Publication Date |
---|---|
SK5692001A3 SK5692001A3 (en) | 2001-12-03 |
SK285271B6 true SK285271B6 (en) | 2006-10-05 |
Family
ID=56289961
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SK569-2001A SK285271B6 (en) | 1998-10-30 | 1999-10-29 | Method for producing 4-[(2',5'-diamino-6'-halopyrimidine-4'- yl)amino]-cyclopent-2-enylmethanols |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP1124805B1 (en) |
JP (1) | JP4457496B2 (en) |
CN (1) | CN1115338C (en) |
AT (1) | ATE240945T1 (en) |
AU (1) | AU1158000A (en) |
CA (1) | CA2348374C (en) |
CZ (1) | CZ300155B6 (en) |
DK (1) | DK1124805T3 (en) |
ES (1) | ES2200594T3 (en) |
HU (1) | HU227559B1 (en) |
IL (1) | IL142760A (en) |
PL (1) | PL198180B1 (en) |
SK (1) | SK285271B6 (en) |
WO (1) | WO2000026193A1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE59905679D1 (en) | 1998-10-30 | 2003-06-26 | Lonza Ag | METHOD FOR PRODUCING 4 - [(2 ', 5'-DIAMINO-6'-HALOGENPYRIMIDIN-4'-YL) AMINO] -CYCLOPENT-2-ENYLMETHANOLS |
DK2805945T3 (en) | 2007-01-10 | 2019-07-15 | Msd Italia Srl | AMID-SUBSTITUTED INDAZOLS AS POLY (ADP-RIBOSE) POLYMERASE (PARP) REQUESTS |
RU2495035C2 (en) | 2008-01-08 | 2013-10-10 | Мерк Шарп Энд Домэ Лтд | Pharmaceutically acceptable salts of 2-{4-[(3s)-piperidin-3-yl]phenyl}-2h-indazole-7-carboxamide |
CN103626745B (en) * | 2013-12-04 | 2016-02-24 | 青岛黄海制药有限责任公司 | A kind of preparation method of ticagrelor midbody |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU203755B (en) * | 1988-01-20 | 1991-09-30 | Univ Minnesota | Process for producing cyclopenentyl-purine derivatives and pharmaceutical compositions containing them |
GB8916698D0 (en) * | 1989-07-21 | 1989-09-06 | Beecham Group Plc | Novel process |
MY104575A (en) * | 1989-12-22 | 1994-04-30 | The Wellcome Foundation Ltd | Therapeutic nucleosides. |
CA2145928C (en) * | 1994-04-27 | 2007-10-09 | Gerhard Stucky | N-(2-amino-4,6-dichloropyrimidin-5-yl)formamide, and a process for its preparation |
ATE283348T1 (en) * | 1996-05-30 | 2004-12-15 | Lonza Ag | METHOD FOR PRODUCING AMINO ALCOHOLS AND DERIVATIVES THEREOF |
-
1999
- 1999-10-29 EP EP99971416A patent/EP1124805B1/en not_active Expired - Lifetime
- 1999-10-29 CA CA002348374A patent/CA2348374C/en not_active Expired - Fee Related
- 1999-10-29 WO PCT/EP1999/008270 patent/WO2000026193A1/en active IP Right Grant
- 1999-10-29 AT AT99971416T patent/ATE240945T1/en active
- 1999-10-29 HU HU0104045A patent/HU227559B1/en not_active IP Right Cessation
- 1999-10-29 CZ CZ20011486A patent/CZ300155B6/en not_active IP Right Cessation
- 1999-10-29 DK DK99971416T patent/DK1124805T3/en active
- 1999-10-29 SK SK569-2001A patent/SK285271B6/en not_active IP Right Cessation
- 1999-10-29 CN CN99812845A patent/CN1115338C/en not_active Expired - Fee Related
- 1999-10-29 ES ES99971416T patent/ES2200594T3/en not_active Expired - Lifetime
- 1999-10-29 AU AU11580/00A patent/AU1158000A/en not_active Abandoned
- 1999-10-29 IL IL14276099A patent/IL142760A/en not_active IP Right Cessation
- 1999-10-29 PL PL347503A patent/PL198180B1/en unknown
- 1999-10-29 JP JP2000579582A patent/JP4457496B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JP4457496B2 (en) | 2010-04-28 |
DK1124805T3 (en) | 2003-09-15 |
CN1115338C (en) | 2003-07-23 |
IL142760A (en) | 2005-12-18 |
ATE240945T1 (en) | 2003-06-15 |
CZ300155B6 (en) | 2009-02-25 |
HU227559B1 (en) | 2011-08-29 |
EP1124805B1 (en) | 2003-05-21 |
CZ20011486A3 (en) | 2001-10-17 |
HUP0104045A2 (en) | 2002-05-29 |
ES2200594T3 (en) | 2004-03-01 |
CA2348374C (en) | 2009-04-07 |
HUP0104045A3 (en) | 2002-07-29 |
AU1158000A (en) | 2000-05-22 |
SK5692001A3 (en) | 2001-12-03 |
CA2348374A1 (en) | 2000-05-11 |
WO2000026193A1 (en) | 2000-05-11 |
EP1124805A1 (en) | 2001-08-22 |
JP2003500333A (en) | 2003-01-07 |
CN1325386A (en) | 2001-12-05 |
PL347503A1 (en) | 2002-04-08 |
IL142760A0 (en) | 2002-03-10 |
PL198180B1 (en) | 2008-06-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CZ302967B6 (en) | Crystalline derivatives of 3,3-diphenylpropylamines and process for preparing thereof | |
AU2006248745B2 (en) | Preparation of famciclovir and other purine derivatives | |
SK284596B6 (en) | Process for the preparation of (1S,4R)- or (1R,4S)-4-(2-amino-6- chloro-9-H-purine-9-yl)-2-cyclopentenyl-1-methanol or its salts | |
JP2020528916A (en) | Intermediates useful for the synthesis of selective inhibitors of protein kinases and the process for preparing them | |
SK285271B6 (en) | Method for producing 4-[(2',5'-diamino-6'-halopyrimidine-4'- yl)amino]-cyclopent-2-enylmethanols | |
EP1501838B1 (en) | A process for the preparation of clopidogrel | |
US2621182A (en) | Office | |
SK284852B6 (en) | Process for the manufacture of pyridine-2,3-dicarboxylate compounds and their intermediates | |
US6433170B1 (en) | Method for producing 4-[2',5'-diamino-6'-halopyrimidine-4'-yl)amino]- cyclopent-2-enylmethanols | |
BG64597B1 (en) | Process for the synthesis of chloropurine intermediates | |
KR101304640B1 (en) | Novel n-methylbenzylamine salt of rosuvastatin and process for the preparation thereof | |
JP4790901B2 (en) | Process for producing 4-amino-5-cyanoimidazole derivative and its intermediate | |
EP3794001A1 (en) | Intermediates and processes for the preparation of linagliptin and its salts | |
US5959118A (en) | Process for the preparation of 5-hydroxymethylthiazoles | |
KR100850558B1 (en) | Process for preparing useful in synthesis of atorvastatin | |
MXPA01004227A (en) | Method for producing 4- [(2',5'- diamino- 6'- halopyrimidine- 4'-yl)amino]- cyclopent- 2- enylmethanols | |
CA2182105C (en) | Chloropyrimide intermediates | |
JP2005533037A (en) | Process for preparing (S) -tetrahydro-α- (1-methylethyl) -2-oxo-1 (2H) -pyrimidineacetic acid | |
KR890002250B1 (en) | Process for preparing triazine derivatives | |
JPH0570441A (en) | Production of cyclopenta(d)pyrimidin-4-ones | |
KR20030068853A (en) | Method for preparing of cinnamic acid derivatives | |
CA2150985A1 (en) | Process for the manufacture of terazosin hydrochloride dihydrate | |
GB2086903A (en) | Novel Quinazolinones and Their Use in the Preparation of Triazoloquinazolinone Derivatives | |
GB2104508A (en) | Improved process for the preparation of 2,4,-diamino-5-(3',4',5'-trimethoxy-benzyl) pyrimidine | |
JPH01104041A (en) | N-((2-oxo-1-pyrrolidinyl)acetyl)piperazine derivative, production thereof and remedy for senile dementia |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Patent lapsed due to non-payment of maintenance fees |
Effective date: 20131029 |